New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 27, 2013
09:21 EDTTIF, LDK, DSW, AKRX, NOK, JCP, BWS, MOV, CPRX, SAFM, HITKOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Tiffany & Co. (TIF), up 1%... Movado Group (MOV), up 5%... Brown Shoe Company (BWS), up 4.4%... DSW (DSW), up 2%... Sanderson Farms (SAFM), up 2.3%... ALSO HIGHER: Catalyst Pharmaceutical (CPRX), up 64% after receiving breakthrough therapy designation by FDA... Akorn (AKRX), up 7% after agreeing to buy Hi-Tech Pharmacal (HITK). Hi-Tech also up 22%... DOWN AFTER EARNINGS: LDK Solar (LDK), down 12%. LOWER: J.C. Penney (JCP), down 2% after Bill Ackman's Pershing Square sells 39M shares... Acura Pharmaceuticals (ACUR), down 23.5% after results for a clinical trial's primary endpoint were not statistically significant... Nokia (NOK), down 3.6% after Deutsche Bank says company possibly facing another restructuring.
News For TIF;MOV;AKRX;HITK;BWS;DSW;SAFM;JCP;LDK;CPRX;NOK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 30, 2015
15:20 EDTJCPMoody's raises J.C. Penney liquidity rating to SGL-1 from SGL-2
Moody's Investors Service revised J.C. Penney's rating outlook to positive from stable. Moody's also affirmed the company's Caa1 Corporate Family Rating, and raised the company's Speculative Grade Liquidity rating to SGL-1 from SGL-2. "The rating outlook revision to positive from stable reflects Moody's view that JC Penney's operating performance has shown signs of improvement as a result of better merchandising, cost controls, and integration of its online business" said Moody's Vice President Scott Tuhy. He added, "we have seen positive momentum building for the company to achieve $700M to $800M of adjusted EBITDA, a level in which earnings would fully cover cash flow and interest". The upgrade in the Speculative Grade Liquidity rating primarily reflects the company's improved operating performance as we expect free cash flow to be near break-even levels and the company's meaningful cash balances are sufficient to cover expected seasonal working capital needs.
08:22 EDTCPRXCatalyst Pharmaceutical appoints Dr. Gary Ingenito as Chief Medical Officer
Catalyst Pharmaceuticals announced the appointment of Gary Ingenito, M.D., Ph.D, as Chief Medical Officer. Following Dr. Ingenito’s joining Catalyst, the current Chief Medical Officer, Charles Gorodetzky, M.D., Ph.D, will continue to serve as a consultant to the company.
06:05 EDTNOKNokia inks four-year deal with Bharti Airtel India for 3G network rollout
Subscribe for More Information
June 29, 2015
08:07 EDTCPRXCatalyst Pharmaceutical study results encouraging, says SunTrust
SunTrust believes that data from a study of Catalyst's CPP-109 in patients with Refractory Tourette's Disorder was encouraging. The firm thinks the results provide strong proof-of-concept for the use of GABA minotransferase inhibitors in Tourette's Disorder. SunTrust says that the drug could enable the company's results to beat expectations by a significant amount. It keeps a Buy rating on the shares.
June 28, 2015
18:08 EDTNOKElliott takes roughly 1.3% stake in Alcatel-Lucent, FT says
Subscribe for More Information
June 26, 2015
16:17 EDTNOKInterDigital: ITC to review RID involving Nokia and Microsoft
Subscribe for More Information
12:00 EDTDSWFinish Line rises after Q1 results beat expectations
Subscribe for More Information
05:51 EDTNOKFoxconn expects to be largest handset, tablet ODM/OEM in 2015, DigiTimes says
Foxconn Chairman Terry Guo said the company is set to be the largest OEM/ODM for handsets, tablets and desktops in 2015, reports DigiTimes. Guo added that Foxconn will establish component supply chains to increase its advantage over competitors. Reference Link
June 25, 2015
06:31 EDTNOKMicrosoft focusing on increasing smartphone sales in India, WSJ reports
Subscribe for More Information
June 24, 2015
10:26 EDTJCPStocks with call strike movement; TWTR JCP
Twitter (TWTR) December 40 call option implied volatility increased 1% to 44, J.C. Penney (JCP) November 20 call option implied volatility decreased 5% to 42 according to IVolatility.
10:00 EDTCPRXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:22 EDTCPRXCatalyst Pharmaceutical initiated with a Buy at MLV & Co.
Target $14.
09:10 EDTCPRXOn The Fly: Pre-market Movers
Subscribe for More Information
08:06 EDTCPRXCatalyst Pharmaceutical announces top-line results in vigabatrin trial
Catalyst Pharmaceuticals announced top-line results in an open-label, proof-of-concept trial of CPP-109, vigabatrin, used to treat patients suffering from Tourette's Disorder, or TD, that were refractory to all other previous treatments. One of four patients demonstrated a very clear, clinically significant reduction in tics, and two others showed about a 25% reduction in tics, but without subjective clinical improvement. This proof-of-concept trial of CPP-109 for Treatment-Refractory Tourette's Disorder was conducted by Barbara Coffey M.D., M.S., Co-Principal Investigator and Chief of the Tics and Tourette’s Clinical and Research Program at the Icahn School of Medicine at Mount Sinai in New York, in collaboration with Dr. Jonathan D. Brodie at the NYU Langone Medical Center, the Co-Principal Investigator and lead inventor of this use of GABA-AT inhibitors. The trial was designed to obtain preliminary data regarding clinical effect, dosage, and tolerability of vigabatrin in subjects at least 18 years of age with a DSM-IV-TR diagnosis of Tourette's Disorder, who exhibited unsatisfactory response to all prior treatments.
June 23, 2015
10:37 EDTTIFTiffany sees 'minimal growth' in FY EPS, consensus $4.23
Says plans to increase global square footage 4%-5% annually for the foreseeable future. Sees ability to generate "healthy" free cash flow. Sees demand for products "consistent" with past trends. Says branded jewelry continues to be attractive globally. Says tourism purchases in the U.S. are "definitely down," but seeing pickups in other markets around the world. Comments made by CFO Ralph Nicoletti at the Jefferies 2015 Global Consumer Conference. Tiffany & Co is up 0.9% to $94.06 in morning trading.
June 22, 2015
11:04 EDTNOKNokia says HERE expanding real-time traffic service to 50 countries
Subscribe for More Information
07:17 EDTNOKRegulators to decide by July 27 on Nokia, Alcatel-Lucent deal, Reuters reports
Subscribe for More Information
June 19, 2015
08:56 EDTAKRXAkorn hacked, customer records stolen, CSO reports
Pharmaceutical company Akorn had its computer systems hacked and the perpetrator is ransoming the customer database, which includes more than 50,000 records, back to the company or threatening to sell the data to the highest bidder, reported CSO. When contacted for comment, Akorn confirmed the breach and stated that they were alerting customers and cooperating fully with law enforcement officials, including the DEA. "Although much of the information acquired is publicly available, we are in the process of notifying our valued customers about this incident," Akorn stated. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use